These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2847695)

  • 1. Alpha-melanocyte-stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease.
    Rainero I; Kaye JA; May C; Durso R; Katz DI; Albert ML; Wolfe N; Pinessi L; Friedland RP; Rapoport SI
    Arch Neurol; 1988 Nov; 45(11):1224-7. PubMed ID: 2847695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abnormality of hypothalamic dopaminergic system in neuro-degenerative diseases--evaluation of alpha-melanocyte-stimulating hormone-like immunoreactivity in cerebrospinal fluid].
    Konagaya Y; Konagaya M
    Rinsho Shinkeigaku; 1991 Aug; 31(8):821-5. PubMed ID: 1764856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF alpha-MSH in dementia of the Alzheimer type.
    Rainero I; May C; Kaye JA; Friedland RP; Rapoport SI
    Neurology; 1988 Aug; 38(8):1281-4. PubMed ID: 2840605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered levels of α-melanocyte stimulating hormone in cerebrospinal fluid and plasma of patients with traumatic brain injury.
    Feng G; Feng J; Zhang S; Tong Y; Zhang Q; Yang X; Zhang H
    Brain Res; 2018 Oct; 1696():22-30. PubMed ID: 29859146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
    Jolkkonen J; Soininen H; Halonen T; Ylinen A; Laulumaa V; Laakso M; Riekkinen P
    J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1374-7. PubMed ID: 2433403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid concentrations of alpha-melanocyte-stimulating hormone in bacterial and aseptic meningitis.
    Ichiyama T; Nishikawa M; Hayashi T; Hayashi S; Ryozawa M; Furukawa S
    Acta Paediatr; 2000 Jul; 89(7):803-5. PubMed ID: 10943961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asphyxia-induced release of alpha-melanocyte-stimulating hormone in newborn pigs.
    Kovács J; Julesz J; Mogyoróssy MV; Deli MA; Abrahám CS; Vecsernyés M
    Peptides; 2001 Jul; 22(7):1049-53. PubMed ID: 11445233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity.
    van Dijk KD; Bidinosti M; Weiss A; Raijmakers P; Berendse HW; van de Berg WD
    Eur J Neurol; 2014 Mar; 21(3):388-94. PubMed ID: 23631635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease.
    Costa A; Bini P; Hamze-Sinno M; Moglia A; Franciotta D; Sinforiani E; Ravaglia S; Bole-Feysot C; Hökfelt T; Déchelotte P; Fetissov SO
    J Neuroimmunol; 2011 Dec; 240-241():114-20. PubMed ID: 22078238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
    Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
    Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
    Masson H; Popescu I; Strubel D; Cramer H; Kuntzmann F
    J Am Geriatr Soc; 1990 Jan; 38(1):19-24. PubMed ID: 1688571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
    Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
    Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.
    Cramer H; Rissler K; Rösler N; Strubel D; Schaudt D; Kuntzmann F
    Eur Neurol; 1989; 29(1):1-5. PubMed ID: 2468498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease.
    Madhyastha TM; Askren MK; Zhang J; Leverenz JB; Montine TJ; Grabowski TJ
    Brain; 2015 Sep; 138(Pt 9):2672-86. PubMed ID: 26173859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.
    Mogi M; Harada M; Riederer P; Narabayashi H; Fujita K; Nagatsu T
    Neurosci Lett; 1994 Jan; 165(1-2):208-10. PubMed ID: 8015728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin concentrations in cerebrospinal fluid. A preliminary study in Parkinson's disease.
    Galard R; Catalán R; Montalbán J; Molins A; Miquel F; Castellanos JM
    Eur J Clin Chem Clin Biochem; 1992 May; 30(5):281-4. PubMed ID: 1320947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid homovanillic acid in the DATATOP study on Parkinson's disease. Parkinson Study Group.
    Arch Neurol; 1995 Mar; 52(3):237-45. PubMed ID: 7872875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid choline in extrapyramidal disorders.
    Aquilonius SM; Nyström B; Schuberth J; Sundwall A
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):720-5. PubMed ID: 4263743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
    Schmid SP; Schleicher ED; Cegan A; Deuschle C; Baur S; Hauser AK; Synofzik M; Srulijes K; Brockmann K; Berg D; Maetzler W
    Mov Disord; 2012 Feb; 27(2):288-92. PubMed ID: 22021190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.